Browse studies

Find your next paid study

26,753 recruiting studies available now

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Baricitinib to Preserve Beta Cell Function in Participants Newly Diagnosed With Type 1 Diabetes Aged ≥1 to <36 Years

The purpose of this study is to find out if baricitinib can preserve beta-cell function in participants newly diagnosed with type 1 diabetes. Participation in …

Diabetes Mellitus, Type 1

Estimated

~$10 – $7,500

Eli Lilly and CompanyNCT07222332

Phase 2

Randomized Phase II Study of Belumosudil vs. Placebo for Preemptive Treatment of Chronic Graft Versus Host Disease

This phase II trial compares the effect of belumosudil to a placebo in treating patients with chronic graft versus host disease. Chronic graft versus host dise…

Chronic Graft Versus Host Disease

Estimated

~$10 – $6,250

Fred Hutchinson Cancer CenterNCT05996627

Observational

Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients

This clinical trial tests the effect of low-intensity mechanical stimulation (LIMS) vibration therapy in patients with hematologic malignancies. Patients with …

Hematopoietic and Lymphoid System Neoplasm

Estimated

~$10 – $7,500

Roswell Park Cancer InstituteNCT05893940

Phase 1

A Phase 1b/2 Open-label Study Evaluating Different MK-6070 and Ifinatamab Deruxtecan (MK-2400)-Based Regimens in First-line Extensive Stage Small Cell Lung Cancer

Researchers are looking for new ways to treat extensive-stage small cell lung cancer (ES-SCLC). ES-SCLC is a type of lung cancer that has spread throughout the…

Small Cell Lung Cancer Extensive Stage

Estimated

~$10 – $8,750

Merck Sharp & Dohme LLCNCT07227597

Phase 2

A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-8690 in Adult Participants With Moderately to Severely Active Ulcerative Colitis

The purpose of this protocol is to evaluate the efficacy of MK-8690 in participants with moderately to severely active ulcerative colitis. The primary hypothes…

Colitis UlcerativeUlcerative Colitis

Estimated

~$10 – $8,750

Merck Sharp & Dohme LLCNCT07463183

Observational

Investigation on the Bidirectional Cortical Neuroprosthetic System

The Bidirectional Cortical Neuroprosthetic System (BiCNS) consists of NeuroPort Microelectrode Array Systems and NeuroPort Electrodes (Sputtered Iridium Oxide …

TetraplegiaQuadriplegia

Estimated

~$10 – $6,250

Johns Hopkins UniversityNCT03161067

Phase 1

A PHASE 1, NON-RANDOMIZED, OPEN-LABEL, SINGLE-DOSE, PARALLEL GROUP STUDY TO COMPARE THE PHARMACOKINETICS OF ATIRMOCICLIB IN ADULT PARTICIPANTS WITH VARYING DEGREES OF HEPATIC IMPAIRMENT RELATIVE TO PARTICIPANTS WITH NORMAL HEPATIC FUNCTION

The purpose of this study to understand how the study medicine atirmociclib behaves in the body and how safe it is for people with different levels of liver he…

Hepatic ImpairmentHealthy, Hepatic InsufficiencyHealthy Adults

A Phase 2, Open-Label, Randomized, Master Protocol Dose Optimization Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations With Mirvetuximab Soravtansine in Subjects With Ovarian Cancer

Ovarian cancer is a lethal disease with an estimated 310,000 new cases and 200,000 deaths experienced worldwide in 2020. The purpose of this study is to assess…

Registry of Asthma Characterization and Recruitment 3 (RACR3) (CAUSE-02)

This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future D…

Asthma

Estimated

~$10 – $675

National Institute of Allergy and Infectious Diseases (NIAID)NCT05272241

Phase 3

A Phase 3, Open-label Study of Ifinatamab Deruxtecan Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (IDeate-Prostate01)

Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC). Researchers have designed a study medicine called ifinat…

Prostate CancerProstatic Neoplasms

Estimated

~$10 – $8,750

Merck Sharp & Dohme LLCNCT06925737

Phase 1

Phase I Pilot Trial of Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS Lymphomas

This research study is for people who have been diagnosed with large B-cell lymphoma of the central nervous system (CNS), which has either returned or is not r…

Large B-cell LymphomaCentral Nervous System Lymphoma

Estimated

~$10 – $7,500

Allison WinterNCT07608731

Phase 1

Phase I/IB Trial of Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

The survival rate for patients with pancreatic cancer remains at a dismal 10% or less at 5 years, and although trials integrating stereotactic body radiation t…

Pancreatic Cancer

Estimated

~$10 – $6,250

Washington University School of MedicineNCT06141031